Download PDF
Thromb Haemost 1992; 67(02): 281
DOI: 10.1055/s-0038-1648426
Letters to the Editor
Schattauer GmbH Stuttgart

The Poor Reliability of Factor X Chromogenic Assays in Coumarin Treated Patients

Antonio Girolami
University of Padua Medical School, Institute of Medical Semeiotics and 4th Chair of Internal Medicine, Padua, Italy
,
Maria Teresa Sartori
University of Padua Medical School, Institute of Medical Semeiotics and 4th Chair of Internal Medicine, Padua, Italy
,
Giuseppe Boeri
University of Padua Medical School, Institute of Medical Semeiotics and 4th Chair of Internal Medicine, Padua, Italy
› Author Affiliations
Further Information

Publication History

Received 11 July 1991

Accepted after revision 21 August 1991

Publication Date:
02 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Han P, Fung KP, Rahdakrishnan U. Lack of agreement of chromogenic and clotting assays for factor X and protein C in warfarinized plasma. Thromb Haemostas 1991; 65: 360-363
    PubMedSearch in Google Scholar
  • 2 Girolami A, Patrassi GM, Toffanin F, Saggin L. Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias. Am J Clin Pathol 1980; 74: 83-87
    CrossrefPubMedSearch in Google Scholar
  • 3 Vasse M, Borg JY, Monconduit M. Protein C: Rouen, a new hereditary protein C abnormality with low anticoagulant but normal amidolytic activities. Thromb Res 1989; 56: 387-398
    CrossrefPubMedSearch in Google Scholar
  • 4 Girolami A. A tentative classification of AT III congenital abnormalities. Folia Haematol 1987; 114: 661-669
    PubMedSearch in Google Scholar
  • 5 Girolami A, Saggin L, Boeri G. Factor X assays using chromogenic substrate S-2222. Am J Clin Pathol 1980; 73: 400-402
    CrossrefPubMedSearch in Google Scholar
  • 6 Van Wijk EM, Kahle LH, Ten Cate JK. Mechanized amidolytic technique for determination of factor X and factor X antigen, and its application to patients being treated with oral anticoagulants. Clin Chem 1980; 26: 885-890
    PubMedSearch in Google Scholar
  • 7 Girolami A, Saggin L, Gazzetta R, Saltarin P. Chromogenic substrate (S-2222) factor X assay in the follow-up of coumarin treated patients. No advantages over Prothrombin Time and/or Thrombotest. Folia Haematol 1980; 108: 610-616
    PubMedSearch in Google Scholar
  • 8 Girolami A, Brunetti A, Bareggi G. Factor X level in coumarin treated patients and in factor X deficiency as assayed by different techniques. Blut 1972; 25: 77-84
    CrossrefPubMedSearch in Google Scholar
  • 9 Lammle B, Bounameaux H, Marbet GA, Eichlisherger R, Duckert F. Monitoring of oral anticoagulation by an amidolytic factor X assay. Thromb Haemostas 1980; 44: 150-153
    PubMedSearch in Google Scholar
  • 10 Stormorken H. A new era in the laboratory evaluation of coagulation and fibrinolysis. Thromb Haemostas 1976; 36: 299-301
    PubMedSearch in Google Scholar